Sexually Dimorphic Regulation of Inhibin Beta B in Establishing Gonadal Vasculature in Mice

Department of Veterinary Biosciences, University of Illinois at Urbana-Champaign, Urbana, Illinois 61802, USA.
Biology of Reproduction (Impact Factor: 3.32). 06/2006; 74(5):978-83. DOI: 10.1095/biolreprod.105.050286
Source: PubMed


Sexually dimorphic differentiation of gonads is accomplished through balanced interactions between positive and negative regulators. One of the earliest features of gonadal differentiation is the divergent patterning of the vasculature. A male-specific coelomic vessel develops on the anterior to posterior of the XY gonad, whereas this vessel is absent in XX gonads. It is postulated that the testis-determining gene Sry controls formation of the coelomic vessel, but the exact molecular mechanism remains unknown. Here we reveal a novel role for inhibin beta B in establishing sex-specific gonad vasculature. In the testis, inhibin beta B contributes to proper formation of the coelomic vessel, a male-specific artery critical for testis development and, later in development, hormone transportation. On the other hand, in the ovary, inhibin beta B is repressed by WNT4 and its downstream target follistatin, leading to the absence of the coelomic vessel. When either Wnt4 or follistatin was inactivated, the coelomic vessel appeared ectopically in the XX ovary. However, when inhibin beta B was also removed in either the Wnt4-null or follistatin-null background, normal ovarian development was restored and no coelomic vessel was found. Our results indicate that the sex-specific formation of the coelomic vessel is established by positive components in the testis as well as an antagonizing pathway from the ovary. Inhibin beta B is strategically positioned at the intersection of these opposing pathways.

Download full-text


Available from: Humphrey Hung-Chang Yao, Mar 17, 2014
  • Source
    • "Tumors obtained from mice were homogenized and cells lysed prior to RNA extractions and cDNA synthesis as described previously (29). For quantitative real-time PCR (q-PCR), four tumors in each group [control, paclitaxel-treated, CYT387-treated, and paclitaxel+CYT387-treated] were analyzed in triplicate as described previously (32). Each gene was validated by using an amplified, purified, and sequenced PCR fragment (originating from HEY cell line) as a positive control. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Chemotherapy resistance associated with recurrent disease is the major cause of poor survival of ovarian cancer patients. We have recently demonstrated activation of the JAK2/STAT3 pathway and the enhancement of a cancer stem cell (CSC)-like phenotype in ovarian cancer cells treated in vitro with chemotherapeutic agents. To elucidate further these mechanisms in vivo, we used a two tiered paclitaxel treatment approach in nude mice inoculated with ovarian cancer cells. In the first approach, we demonstrate that a single intraperitoneal administration of paclitaxel in mice 7 days after subcutaneous transplantation of the HEY ovarian cancer cell line resulted in a significant increase in the expression of CA125, Oct4 and CD117 in mice xenografts compared to control mice xenografts which did not receive paclitaxel. In the second approach, mice were administered once weekly with paclitaxel and/or a daily dose of the JAK2 specific inhibitor, CYT387, over four weeks. Mice receiving paclitaxel only demonstrated a significant decrease in tumor volume compared to control mice. At the molecular level, mouse tumors remaining after paclitaxel administration showed a significant increase in the expression of Oct4 and CD117 coinciding with a significant activation of the JAK2/STAT3 pathway compared to control tumors. The addition of CYT387 with paclitaxel resulted in the suppression of JAK2/STAT3 activation and abrogation of Oct4 and CD117 expression in mouse xenografts. This coincided with significantly smaller tumors in mice administered CYT387 in addition to paclitaxel, compared to the control group and the group of mice receiving paclitaxel only. These data suggest that the systemic administration of paclitaxel enhances Oct4 and CD117 associated CSC-like marker expression in surviving cancer cells in vivo, which can be suppressed by the addition of the JAK2 specific inhibitor CYT387, leading to a significantly smaller tumor burden. These novel findings have the potential for
    Full-text · Article · Apr 2014 · Frontiers in Oncology
  • Source
    • "The characterization of female knockout (XX Fst –/– ) mice during early ovarian development demonstrated that FST is implicated in the inhibition of testicular vasculature formation and in oocyte survival downstream of Wnt4 [Yao et al., 2004]. Action of FST through the inhibition of activins is also suspected , as activin B is known to be implicated in coelomic vessel formation [Yao et al., 2006], and inhibition of activin B in Fst –/– or Wnt4 –/– mice restores a normal ovarian development, including germ cells survival [Liu et al., 2010]. In rainbow trout, Fst function during early ovarian differentiation is unknown, and a potential role of activins should be investigated. "
    [Show abstract] [Hide abstract]
    ABSTRACT: In mammals, follistatin (FST) plays an important role in early ovarian differentiation, acting downstream of the Wnt pathway. In teleost fish, fst is implicated in folliculogenesis and oocyte maturation, and an early and specific expression during ovarian differentiation has been described in rainbow trout, Oncorhynchus mykiss. By in situ hybridization, we demonstrated that during rainbow trout gonadal differentiation, fst shares a similar expression pattern with cyp19a1a, the gene encoding ovarian aromatase, a key steroidogenic enzyme needed for ovarian differentiation in fish. Expression of fst and cyp19a1a was first detected in a few scattered cells in the embryonic ovary several days before hatching. Then, after histological differentiation, fst and cyp19a1a expression was localized in clusters of cells lining the future ovarian lamellae. As FST expression is known to be induced by the Wnt/β-catenin pathway in mammals, the Wnt pathway was inhibited in vivo with the IWR-1 molecule, and we analyzed by qPCR the effects of this treatment on fst expression. We found that IWR-1 decreased fst expression in female gonads, consistent with a regulation of fst expression by the Wnt pathway in rainbow trout. Furthermore, expression of cyp19a1a was also downregulated, suggesting an implication of the Wnt pathway in ovarian differentiation.
    Full-text · Article · Apr 2013 · Sexual Development
  • Source
    • "Fst knockout mice (Fst À/À ) mice have normal numbers of PGCs through E15.5 (Yao et al., 2004), but have lost all germ cells by birth due to apoptosis that begins around E16.6 (Yao et al., 2004). This appears to be due to activindriven apoptosis of germ cells (Liu et al., 2010b), and accordingly, deletion of the activin b subunit (Inhbb) from Fst À/À restores normal ovarian development (Yao et al., 2006). Thus, changes in follistatin–activin signaling in the developing embryonic ovary could have clinically important "
    [Show abstract] [Hide abstract]
    ABSTRACT: Genetic or environmental factors that affect the endowment of oocytes, their assembly into primordial follicles, or their subsequent entry into the growing follicle pool can disrupt reproductive function and may underlie disorders such as primary ovarian insufficiency. Mouse models have been instrumental in identifying genes important in ovarian development, and a number of genes now associated with ovarian dysfunction in women were first identified as causing reproductive defects in knockout mice. The transforming growth factor beta (TGFB) family consists of developmentally important growth factors that include the TGFBs, anti-Müllerian hormone (AMH), activins, bone morphogenetic proteins (BMPs), and growth and differentiation factor 9 (GDF9). The ovarian primordial follicle pool is the source of oocytes in adults. Development of this pool can be grossly divided into three key processes: (1) establishment of oocytes during embryogenesis followed by (2) assembly and (3) activation of the primordial follicle. Disruptions in any of these processes may cause reproductive dysfunction. Most members of the TGFB family show pivotal roles in each of these areas. Understanding the phenotypes of various mouse models for this protein family will be directly relevant to understanding how disruptions in TGFB family signaling result in reproductive diseases in women and will present new areas for development of tailored diagnostics and interventions for infertility. Mol. Reprod. Dev. 79: 666-679, 2012. © 2012 Wiley Periodicals, Inc.
    Full-text · Article · Oct 2012 · Molecular Reproduction and Development
Show more